Description

Gly-Mal-Gly-Gly-Phe-Gly-amide-methylcyclopropane-Exatecan is used for ADC Synthesis[1].–Applications-Cancer-programmed cell death-Formula-C54H57FN10O15-Citation–References-[1]Zhu Yi, et al. Camptothecin derivative and ligand-drug conjugate thereof. World Intellectual Property Organization, WO2022078260 A1. 2022-04-21.-CASNumber-2766786-76-7-MolecularWeight-1105.09-Compound Purity–SMILES-OC(CNC[C@H](N1C(C=CC1=O)=O)C(NCC(NCC(N[C@@H](CC2=CC=CC=C2)C(NCC(NCO[C@@H](C3CC3)C(N[C@H]4C5=C6C(C(N7C6)=CC([C@](O)(C(OC8)=O)CC)=C8C7=O)=NC9=CC(F)=C(C)C(CC4)=C95)=O)=O)=O)=O)=O)=O)=O-Research_Area-Cancer-Solubility-10 mM in DMSO-Target-Drug-Linker Conjugates for ADC;Topoisomerase-Isoform-Camptothecins-Pathway-Antibody-drug Conjugate/ADC Related;Cell Cycle/DNA Damage-MCE Product type-ADC Related